发明名称 |
N,N-DIMETHYL-2-[5-(1,2,4-TRIAZOLE-1-YL-METHYL)-1H-INDOLE-3-YL]-ETHYLAMINE SULFATE SALT (2:1) AND ITS PHARMACEUTICALLY ACCEPTABLE HYDRATES, METHODS OF ITS PREPARING, A PHARMACEUTICAL COMPOSITION ON ITS BASE, A METHOD OF ITS PREPARING AND A DRUG |
摘要 |
FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to a new compound - N,N-dimethyl-2-[5-(1,2,4-triazole-1-yl-methyl)-1H-indole-3-yl]-ethylamine sulfate salt (2:1) of structural formula (I) <EMI ID=0.174 HE=33 WI=72 TI=CHI> and its pharmaceutically acceptable hydrate. Method of producing salt or its hydrate involves an interaction of N,N-dimethyl-2-[5-(1,2,4-triazole-1-yl-methyl)-1H-indole-3-yl]-ethylamine of the formula (II) <EMI ID=0.175 HE=33 WI=54 TI=CHI> with about 0.5 molar equivalent sulfuric acid in a suitable solvent. Invention describes a pharmaceutical composition and a drug for treatment and/or prophylaxis of clinical states where the use of a selective agonist of 5-HT<SB>1</SB>-like receptors is indicated. N, N-Dimethyl-2-[5-(1,2,4-triazole-1-yl-methyl)-1H-indole-3-yl] -ethylamine sulfate salt is a selective agonist of 5-HT<SB>1</SB>-like receptors and therefore is benefit for treatment of patients with clinical disorders, especially migraine and related disorders, where the use of a selective agonist of these receptors is indicated. EFFECT: improved method of preparing, enhanced effectiveness of a drug proposed. 17 cl, 17 ex |
申请公布号 |
RU2130022(C1) |
申请公布日期 |
1999.05.10 |
申请号 |
RU19940046380 |
申请日期 |
1993.05.28 |
申请人 |
MERK SHARP EHND DOM LIMITED |
发明人 |
RAJMOND BEJKER;VIKTOR GILIO MATASSA;KAROL' OLIV;KENDAL DZHORDZH PITT;DEHVID EHDVARD STORI;LESLI DZHOZEF STRIT;ALEKSANDR RICHARD GIBLIN |
分类号 |
A61K9/08;A61K9/20;A61K31/00;A61K31/4045;A61K31/41;A61K31/415;A61K31/4196;A61P1/00;A61P9/08;A61P25/00;A61P25/04;A61P25/06;A61P43/00;C07D403/06;C07D521/00 |
主分类号 |
A61K9/08 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|